Palabras claves: Adverse drug reactions (ADRs), Continuing medical education, Cytochrome P450 enzymes, Education, International Society of Pharmacogenetics (ISP), personalized medicine, pharmacogenetics, Thiopurine methyltransferase (TPMT)
Autores: Adrián LLerena, Dedoussis G., Flordellis C.S., Fuhr U., Gurwitz D., Kirchheiner J., Licinio J., Lunshof J.E., Manolopoulos V.G., Sheffield L.J., Siest G., Torricelli F., Vasiliou V., Wong S.
